HEADER HYDROLASE 13-SEP-02 1MQ0 TITLE CRYSTAL STRUCTURE OF HUMAN CYTIDINE DEAMINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYTIDINE DEAMINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYTIDINE AMINOHYDROLASE; COMPND 5 EC: 3.5.4.5; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET28A KEYWDS HUMAN, ENZYME, CYTIDINE DEAMINASE, AMINE HYDROLASE, INHIBITOR, KEYWDS 2 DIAZEPINONE, LEUKEMIA, CHEMOTHERAPY, ANTICANCER, DRUG, PHI-PHI KEYWDS 3 INTERACTION, EDGE-TO-FACE INTERACTION, PROTEIN, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.CHUNG,J.C.FROMME,G.L.VERDINE REVDAT 6 27-OCT-21 1MQ0 1 REMARK SEQADV LINK REVDAT 5 11-OCT-17 1MQ0 1 REMARK REVDAT 4 13-JUL-11 1MQ0 1 VERSN REVDAT 3 24-FEB-09 1MQ0 1 VERSN REVDAT 2 08-MAR-05 1MQ0 1 JRNL REVDAT 1 04-NOV-03 1MQ0 0 JRNL AUTH S.J.CHUNG,J.C.FROMME,G.L.VERDINE JRNL TITL STRUCTURE OF HUMAN CYTIDINE DEAMINASE BOUND TO A POTENT JRNL TITL 2 INHIBITOR JRNL REF J.MED.CHEM. V. 48 658 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 15689149 JRNL DOI 10.1021/JM0496279 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 210371.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 10555 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 520 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1646 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 83 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.037 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1922 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 19.15000 REMARK 3 B22 (A**2) : -7.11000 REMARK 3 B33 (A**2) : -12.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.51 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.600 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.240 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 51.75 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : CDA_INHIBITOR.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA_REP.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : CDA_INHIBITOR.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1MQ0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-SEP-02. REMARK 100 THE DEPOSITION ID IS D_1000017085. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUL-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NICKEL FILTER REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11082 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 4.580 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.56 REMARK 200 R MERGE FOR SHELL (I) : 0.32600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1JTK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, 2-METHYL-2,4-PENTANE REMARK 280 -DIOL, CALCIUM CHLORIDE, SYNTHETIC INHIBITOR, PH 4.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.19900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.84000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.19900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.84000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A TETRAMER, AND THERE IS A DIMER IN REMARK 300 THE ASYMMETRIC UNIT. THE OTHER DIMER OF THE TETRAMER CAN BE REMARK 300 OBTAINED BY THE FOLLOWING SYMMETRY OPERATION: (-X, -Y,Z) DX=1 DY=3 REMARK 300 DZ=0 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -219.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 52.39800 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 167.04000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 HIS A 9 REMARK 465 MET A 10 REMARK 465 LYS A 11 REMARK 465 PRO A 12 REMARK 465 GLN A 143 REMARK 465 LYS A 144 REMARK 465 THR A 145 REMARK 465 GLN A 146 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 HIS B 9 REMARK 465 MET B 10 REMARK 465 LYS B 11 REMARK 465 PRO B 12 REMARK 465 GLN B 143 REMARK 465 LYS B 144 REMARK 465 THR B 145 REMARK 465 GLN B 146 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 13 CB CG CD OE1 OE2 REMARK 470 CYS A 14 CB SG REMARK 470 GLN A 17 CG CD OE1 NE2 REMARK 470 LEU A 19 CG CD1 CD2 REMARK 470 GLN A 45 CG CD OE1 NE2 REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 ARG A 83 CB CG CD NE CZ NH1 NH2 REMARK 470 GLN A 92 CB CG CD OE1 NE2 REMARK 470 ASP A 93 CB CG OD1 OD2 REMARK 470 ASP A 94 CB CG OD1 OD2 REMARK 470 ILE A 125 CD1 REMARK 470 SER A 135 OG REMARK 470 LEU A 142 CG CD1 CD2 REMARK 470 GLU B 13 CB CG CD OE1 OE2 REMARK 470 CYS B 14 SG REMARK 470 GLN B 27 CG CD OE1 NE2 REMARK 470 SER B 28 OG REMARK 470 GLN B 45 CG CD OE1 NE2 REMARK 470 LYS B 73 CG CD CE NZ REMARK 470 ASP B 81 CG OD1 OD2 REMARK 470 ARG B 83 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 93 CB CG OD1 OD2 REMARK 470 ASN B 112 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN B 92 OE1 GLN B 92 2785 1.46 REMARK 500 OD2 ASP B 94 OD1 ASP B 141 2685 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 14 144.42 174.56 REMARK 500 ASP A 81 -87.45 -82.54 REMARK 500 PHE A 82 119.45 82.03 REMARK 500 ALA A 84 168.03 175.05 REMARK 500 ASP A 94 151.70 111.62 REMARK 500 TRP A 113 153.30 -48.29 REMARK 500 TYR B 60 -53.34 -27.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 147 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 65 SG REMARK 620 2 CYS A 99 SG 108.7 REMARK 620 3 CYS A 102 SG 109.8 115.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 147 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 65 SG REMARK 620 2 CYS B 99 SG 116.2 REMARK 620 3 CYS B 102 SG 99.4 129.4 REMARK 620 4 HOH B 151 O 108.7 100.7 100.3 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 147 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRD A 148 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BRD B 149 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JTK RELATED DB: PDB REMARK 900 CYTIDINE DEAMINASE FROM B. SUBTILIS DBREF 1MQ0 A 11 146 UNP P32320 CDD_HUMAN 11 146 DBREF 1MQ0 B 11 146 UNP P32320 CDD_HUMAN 11 146 SEQADV 1MQ0 GLY A 7 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 SER A 8 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 HIS A 9 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 MET A 10 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 GLN A 27 UNP P32320 LYS 27 ENGINEERED MUTATION SEQADV 1MQ0 GLY B 7 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 SER B 8 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 HIS B 9 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 MET B 10 UNP P32320 CLONING ARTIFACT SEQADV 1MQ0 GLN B 27 UNP P32320 LYS 27 ENGINEERED MUTATION SEQRES 1 A 140 GLY SER HIS MET LYS PRO GLU CYS VAL GLN GLN LEU LEU SEQRES 2 A 140 VAL CYS SER GLN GLU ALA LYS GLN SER ALA TYR CYS PRO SEQRES 3 A 140 TYR SER HIS PHE PRO VAL GLY ALA ALA LEU LEU THR GLN SEQRES 4 A 140 GLU GLY ARG ILE PHE LYS GLY CYS ASN ILE GLU ASN ALA SEQRES 5 A 140 CYS TYR PRO LEU GLY ILE CYS ALA GLU ARG THR ALA ILE SEQRES 6 A 140 GLN LYS ALA VAL SER GLU GLY TYR LYS ASP PHE ARG ALA SEQRES 7 A 140 ILE ALA ILE ALA SER ASP MET GLN ASP ASP PHE ILE SER SEQRES 8 A 140 PRO CYS GLY ALA CYS ARG GLN VAL MET ARG GLU PHE GLY SEQRES 9 A 140 THR ASN TRP PRO VAL TYR MET THR LYS PRO ASP GLY THR SEQRES 10 A 140 TYR ILE VAL MET THR VAL GLN GLU LEU LEU PRO SER SER SEQRES 11 A 140 PHE GLY PRO GLU ASP LEU GLN LYS THR GLN SEQRES 1 B 140 GLY SER HIS MET LYS PRO GLU CYS VAL GLN GLN LEU LEU SEQRES 2 B 140 VAL CYS SER GLN GLU ALA LYS GLN SER ALA TYR CYS PRO SEQRES 3 B 140 TYR SER HIS PHE PRO VAL GLY ALA ALA LEU LEU THR GLN SEQRES 4 B 140 GLU GLY ARG ILE PHE LYS GLY CYS ASN ILE GLU ASN ALA SEQRES 5 B 140 CYS TYR PRO LEU GLY ILE CYS ALA GLU ARG THR ALA ILE SEQRES 6 B 140 GLN LYS ALA VAL SER GLU GLY TYR LYS ASP PHE ARG ALA SEQRES 7 B 140 ILE ALA ILE ALA SER ASP MET GLN ASP ASP PHE ILE SER SEQRES 8 B 140 PRO CYS GLY ALA CYS ARG GLN VAL MET ARG GLU PHE GLY SEQRES 9 B 140 THR ASN TRP PRO VAL TYR MET THR LYS PRO ASP GLY THR SEQRES 10 B 140 TYR ILE VAL MET THR VAL GLN GLU LEU LEU PRO SER SER SEQRES 11 B 140 PHE GLY PRO GLU ASP LEU GLN LYS THR GLN HET ZN A 147 1 HET BRD A 148 17 HET ZN B 147 1 HET BRD B 149 17 HETNAM ZN ZINC ION HETNAM BRD 1-BETA-RIBOFURANOSYL-1,3-DIAZEPINONE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 BRD 2(C10 H14 N2 O5) FORMUL 7 HOH *62(H2 O) HELIX 1 1 CYS A 14 LYS A 26 1 13 HELIX 2 2 GLN A 27 ALA A 29 5 3 HELIX 3 3 CYS A 59 GLY A 63 5 5 HELIX 4 4 CYS A 65 GLU A 77 1 13 HELIX 5 5 CYS A 99 GLU A 108 1 10 HELIX 6 6 VAL A 129 LEU A 133 1 5 HELIX 7 7 GLY A 138 LEU A 142 5 5 HELIX 8 8 CYS B 14 LYS B 26 1 13 HELIX 9 9 GLN B 27 ALA B 29 5 3 HELIX 10 10 CYS B 59 GLY B 63 5 5 HELIX 11 11 CYS B 65 SER B 76 1 12 HELIX 12 12 CYS B 99 PHE B 109 1 11 HELIX 13 13 VAL B 129 LEU B 133 1 5 HELIX 14 14 GLY B 138 LEU B 142 5 5 SHEET 1 A 5 ILE A 49 CYS A 53 0 SHEET 2 A 5 VAL A 38 LEU A 43 -1 N LEU A 42 O PHE A 50 SHEET 3 A 5 ALA A 84 SER A 89 -1 O ALA A 84 N LEU A 43 SHEET 4 A 5 PRO A 114 THR A 118 1 O TYR A 116 N ILE A 85 SHEET 5 A 5 TYR A 124 THR A 128 -1 O ILE A 125 N MET A 117 SHEET 1 B 5 ILE B 49 CYS B 53 0 SHEET 2 B 5 VAL B 38 THR B 44 -1 N LEU B 42 O PHE B 50 SHEET 3 B 5 PHE B 82 SER B 89 -1 O ALA B 88 N GLY B 39 SHEET 4 B 5 PRO B 114 THR B 118 1 O TYR B 116 N ILE B 85 SHEET 5 B 5 TYR B 124 THR B 128 -1 O MET B 127 N VAL B 115 LINK SG CYS A 65 ZN ZN A 147 1555 1555 2.55 LINK SG CYS A 99 ZN ZN A 147 1555 1555 2.46 LINK SG CYS A 102 ZN ZN A 147 1555 1555 2.39 LINK SG CYS B 65 ZN ZN B 147 1555 1555 2.49 LINK SG CYS B 99 ZN ZN B 147 1555 1555 2.30 LINK SG CYS B 102 ZN ZN B 147 1555 1555 2.41 LINK ZN ZN B 147 O HOH B 151 1555 1555 2.40 SITE 1 AC1 4 CYS A 65 GLU A 67 CYS A 99 CYS A 102 SITE 1 AC2 4 CYS B 65 CYS B 99 CYS B 102 HOH B 151 SITE 1 AC3 12 PHE A 36 VAL A 38 ASN A 54 GLU A 56 SITE 2 AC3 12 ILE A 64 CYS A 65 ALA A 66 GLU A 67 SITE 3 AC3 12 HOH A 159 ALA B 58 CYS B 59 TYR B 60 SITE 1 AC4 15 ALA A 58 CYS A 59 TYR A 60 PRO A 61 SITE 2 AC4 15 PHE B 36 VAL B 38 ASN B 54 GLU B 56 SITE 3 AC4 15 ILE B 64 CYS B 65 ALA B 66 GLU B 67 SITE 4 AC4 15 SER B 97 HOH B 151 HOH B 157 CRYST1 52.398 55.680 90.689 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019085 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017960 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011027 0.00000 MASTER 373 0 4 14 10 0 9 6 0 0 0 22 END